Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials

Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials

Summary: Salivary gland cancers (SGCs) are heterogeneous tumors, and precision oncology represents a promising therapeutic approach; however, its impact on SGCs remains obscure. This study aimed to establish a translational model for testing molecular-targeted therapies by combining patient-derived...

Full description

Bibliographic Details
Main Authors: Tomohiko Ishikawa, Takenori Ogawa, Masahiro Shiihara, Hajime Usubuchi, Yuko Omori, Katsuya Hirose, Taito Itoh, Takuya Yoshida, Ayako Nakanome, Akira Okoshi, Kenjiro Higashi, Ryo Ishii, Masahiro Rokugo, Shun Wakamori, Yasunobu Okamura, Kengo Kinoshita, Yukio Katori, Toru Furukawa
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:iScience
Subjects:
Health sciences
Cell biology
Stem cells research
Cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004223007721

Internet

http://www.sciencedirect.com/science/article/pii/S2589004223007721

Similar Items